Table 1.
Clinical characteristics of the patients included in analyses of RFC4 expression evaluated by qPCR, Western and IHC
| Characteristics | qPCR cases (n = 30 pairs) | Western cases (n = 16 pairs) | IHC cases (n = 49 pairs) |
|---|---|---|---|
| Age (years) Mean ± SD | 57.8 ± 10.9 | 56.8 ± 11.2 | 64.0 ± 12.3 |
| Sex | |||
| Female | 6 (20.0%) | 5 (31.2%) | 16 (32.7%) |
| Male | 24 (80.0%) | 11 (68.8%) | 33 (67.3%) |
| Tumor location | |||
| Colon | 16 (53.3%) | 9 (56.3%) | 23 (46.9%) |
| Rectal | 14 (46.7%) | 7 (43.7%) | 26 (53.1%) |
| Differentiation | |||
| Well | 5 (16.7%) | 2 (12.5%) | 6 (12.2%) |
| Moderate | 21 (70.0%) | 12 (75.0%) | 37 (75.6%) |
| Poorly | 4 (13.3%) | 2 (12.5%) | 6 (12.2%) |
| TNM stage | |||
| I | 3 (10.0%) | 2 (12.5%) | 6 (12.2%) |
| II | 19 (63.3%) | 9 (56.3%) | 18 (36.8%) |
| III | 8 (26.7%) | 5 (31.2%) | 22 (44.9%) |
| IV | 0 (0%) | 0 (0%) | 3 (6.1%) |